Loading the section…

MPT: financial statements from SEC — TradeAlmanac

MPT

Medical Properties Trust, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	252M	238M	240M	224M	226M	267M
Selling, general and administrative	32M	38M	26M	42M	37M	35M
Operating expenses	245M	246M	233M	229M	353M	247M
Interest expense	133M	132M	130M	116M	106M	101M
Pre-tax income	285,000	−67M	−88M	−109M	−792M	−305M
Income tax	−33M	11M	10M	9M	9M	15M
Net income	33M	−78M	−98M	−118M	−801M	−320M
Earnings per share	0.05	−0.13	−0.16	−0.20	−1.34	−0.54
Earnings per share, diluted	0.05	−0.13	−0.16	−0.20	−1.34	−0.54
Weighted average shares	598M	601M	601M	601M	600M	600M
Weighted average shares, diluted	598M	601M	601M	601M	600M	600M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	425M	541M	397M	510M	673M	332M	276M	607M
Total assets	14.76B	15.00B	14.92B

Cash flow

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	−14M	—	—	384,000	—	—
Depreciation and amortisation	73M	67M	67M	65M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator